Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab for Non-cystic Fibrosis Bronchiectasis Exacerbations (MAHALE, China)
CTR20212295Phase 3Terminated
- Sponsor
- AstraZeneca
- Start
- Sep 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of benralizumab in bronchiectasis, sponsored by AstraZeneca. Started Sep 2021; status: terminated.
02
Drugs
benralizumab
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on CTR20212295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212295.